Organ Transplantation Immunosuppressive Drug Market Report

Europe Organ Transplantation Immunosuppressive Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 25, 2019
  • PAGES：149
  • REPORT CODE：GMM349267
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Organ Transplantation Immunosuppressive Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Organ Transplantation Immunosuppressive Drug Market Segmentations:

    By Player:

    • Bristol-Myers Squibb Company.

    • AbbVie, Inc.

    • F.Hoffmann-La Roche Ltd.

    • Novartis Pharmaceuticals Corporation

    • Astellas Pharma, Inc.

    • GlaxoSmithKline plc

    • Pfizer, Inc.

    • FHoffmann-La Roche Ltd.

    • Genzyme Corporation（Sanofi SA）

    • Veloxis Pharmaceuticals A/S

    By Type:

    • Calcineurin Inhibitors

    • Antiproliferative Agents

    • mTOR Inhibitors

    • Antibodies

    • Steroids

    By End-User:

    • Kidney

    • Bone Marrow

    • Liver

    • Heart

    • Lungs

    • Others (Intestinal and Multi-visceral Organs)

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Organ Transplantation Immunosuppressive Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Calcineurin Inhibitors from 2014 to 2026

    • 1.3.2 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Antiproliferative Agents from 2014 to 2026

    • 1.3.3 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of mTOR Inhibitors from 2014 to 2026

    • 1.3.4 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Antibodies from 2014 to 2026

    • 1.3.5 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Steroids from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Kidney from 2014 to 2026

    • 1.4.2 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Bone Marrow from 2014 to 2026

    • 1.4.3 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Liver from 2014 to 2026

    • 1.4.4 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Heart from 2014 to 2026

    • 1.4.5 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Lungs from 2014 to 2026

    • 1.4.6 Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Others (Intestinal and Multi-visceral Organs) from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Organ Transplantation Immunosuppressive Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Organ Transplantation Immunosuppressive Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Calcineurin Inhibitors

      • 3.4.2 Market Size and Growth Rate of Antiproliferative Agents

      • 3.4.3 Market Size and Growth Rate of mTOR Inhibitors

      • 3.4.4 Market Size and Growth Rate of Antibodies

      • 3.4.5 Market Size and Growth Rate of Steroids

    4 Segmentation of Organ Transplantation Immunosuppressive Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Organ Transplantation Immunosuppressive Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Organ Transplantation Immunosuppressive Drug for Kidney

      • 4.4.2 Market Size and Growth Rate of Organ Transplantation Immunosuppressive Drug for Bone Marrow

      • 4.4.3 Market Size and Growth Rate of Organ Transplantation Immunosuppressive Drug for Liver

      • 4.4.4 Market Size and Growth Rate of Organ Transplantation Immunosuppressive Drug for Heart

      • 4.4.5 Market Size and Growth Rate of Organ Transplantation Immunosuppressive Drug for Lungs

      • 4.4.6 Market Size and Growth Rate of Organ Transplantation Immunosuppressive Drug for Others (Intestinal and Multi-visceral Organs)

    5 Market Analysis by Major Regions

    • 5.1 Europe Organ Transplantation Immunosuppressive Drug Production Analysis by Top Regions

    • 5.2 Europe Organ Transplantation Immunosuppressive Drug Consumption Analysis by Top Regions

    • 5.3 Europe Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Organ Transplantation Immunosuppressive Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 7.1 Germany Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 7.2 Germany Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    8. UK Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 8.1 UK Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 8.2 UK Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    9. France Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 9.1 France Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 9.2 France Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    10. Italy Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 10.1 Italy Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 10.2 Italy Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    11. Spain Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 11.1 Spain Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 11.2 Spain Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    12. Poland Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 12.1 Poland Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 12.2 Poland Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    13. Russia Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 13.1 Russia Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 13.2 Russia Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    14. Switzerland Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 14.1 Switzerland Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    15. Turkey Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 15.1 Turkey Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 15.2 Turkey Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 16.3.2 Finland Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 16.3.3 Norway Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Bristol-Myers Squibb Company.

      • 19.1.1 Bristol-Myers Squibb Company. Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 AbbVie, Inc.

      • 19.2.1 AbbVie, Inc. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 F.Hoffmann-La Roche Ltd.

      • 19.3.1 F.Hoffmann-La Roche Ltd. Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Novartis Pharmaceuticals Corporation

      • 19.4.1 Novartis Pharmaceuticals Corporation Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Astellas Pharma, Inc.

      • 19.5.1 Astellas Pharma, Inc. Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 GlaxoSmithKline plc

      • 19.6.1 GlaxoSmithKline plc Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Pfizer, Inc.

      • 19.7.1 Pfizer, Inc. Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 FHoffmann-La Roche Ltd.

      • 19.8.1 FHoffmann-La Roche Ltd. Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Genzyme Corporation（Sanofi SA）

      • 19.9.1 Genzyme Corporation（Sanofi SA） Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Veloxis Pharmaceuticals A/S

      • 19.10.1 Veloxis Pharmaceuticals A/S Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 90 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Calcineurin Inhibitors from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Antiproliferative Agents from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of mTOR Inhibitors from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Antibodies from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Steroids from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Kidney from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Bone Marrow from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Liver from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Heart from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Lungs from 2014 to 2026

    • Figure Europe Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate of Others (Intestinal and Multi-visceral Organs) from 2014 to 2026

    • Figure Germany Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Organ Transplantation Immunosuppressive Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Organ Transplantation Immunosuppressive Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Organ Transplantation Immunosuppressive Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Organ Transplantation Immunosuppressive Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Organ Transplantation Immunosuppressive Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Calcineurin Inhibitors

    • Figure Market Size and Growth Rate of Antiproliferative Agents

    • Figure Market Size and Growth Rate of mTOR Inhibitors

    • Figure Market Size and Growth Rate of Antibodies

    • Figure Market Size and Growth Rate of Steroids

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Organ Transplantation Immunosuppressive Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Organ Transplantation Immunosuppressive Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Kidney

    • Figure Market Size and Growth Rate of Bone Marrow

    • Figure Market Size and Growth Rate of Liver

    • Figure Market Size and Growth Rate of Heart

    • Figure Market Size and Growth Rate of Lungs

    • Figure Market Size and Growth Rate of Others (Intestinal and Multi-visceral Organs)

    • Table Europe Organ Transplantation Immunosuppressive Drug Production by Major Regions

    • Table Europe Organ Transplantation Immunosuppressive Drug Production Share by Major Regions

    • Figure Europe Organ Transplantation Immunosuppressive Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Organ Transplantation Immunosuppressive Drug Consumption by Major Regions

    • Table Europe Organ Transplantation Immunosuppressive Drug Consumption Share by Major Regions

    • Table Germany Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table UK Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table France Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Italy Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Spain Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Poland Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Russia Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Organ Transplantation Immunosuppressive Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Germany Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table UK Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table UK Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table UK Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table France Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table France Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table France Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Italy Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Spain Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Poland Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Russia Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Turkey Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Organ Transplantation Immunosuppressive Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Organ Transplantation Immunosuppressive Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Organ Transplantation Immunosuppressive Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Organ Transplantation Immunosuppressive Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company.

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company.

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company.

    • Table Product and Service Introduction of Bristol-Myers Squibb Company.

    • Table Company Profile and Development Status of AbbVie, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie, Inc.

    • Figure Sales and Growth Rate Analysis of AbbVie, Inc.

    • Figure Revenue and Market Share Analysis of AbbVie, Inc.

    • Table Product and Service Introduction of AbbVie, Inc.

    • Table Company Profile and Development Status of F.Hoffmann-La Roche Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F.Hoffmann-La Roche Ltd.

    • Figure Sales and Growth Rate Analysis of F.Hoffmann-La Roche Ltd.

    • Figure Revenue and Market Share Analysis of F.Hoffmann-La Roche Ltd.

    • Table Product and Service Introduction of F.Hoffmann-La Roche Ltd.

    • Table Company Profile and Development Status of Novartis Pharmaceuticals Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Pharmaceuticals Corporation

    • Figure Sales and Growth Rate Analysis of Novartis Pharmaceuticals Corporation

    • Figure Revenue and Market Share Analysis of Novartis Pharmaceuticals Corporation

    • Table Product and Service Introduction of Novartis Pharmaceuticals Corporation

    • Table Company Profile and Development Status of Astellas Pharma, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma, Inc.

    • Figure Sales and Growth Rate Analysis of Astellas Pharma, Inc.

    • Figure Revenue and Market Share Analysis of Astellas Pharma, Inc.

    • Table Product and Service Introduction of Astellas Pharma, Inc.

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Pfizer, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc.

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc.

    • Figure Revenue and Market Share Analysis of Pfizer, Inc.

    • Table Product and Service Introduction of Pfizer, Inc.

    • Table Company Profile and Development Status of FHoffmann-La Roche Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FHoffmann-La Roche Ltd.

    • Figure Sales and Growth Rate Analysis of FHoffmann-La Roche Ltd.

    • Figure Revenue and Market Share Analysis of FHoffmann-La Roche Ltd.

    • Table Product and Service Introduction of FHoffmann-La Roche Ltd.

    • Table Company Profile and Development Status of Genzyme Corporation（Sanofi SA）

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genzyme Corporation（Sanofi SA）

    • Figure Sales and Growth Rate Analysis of Genzyme Corporation（Sanofi SA）

    • Figure Revenue and Market Share Analysis of Genzyme Corporation（Sanofi SA）

    • Table Product and Service Introduction of Genzyme Corporation（Sanofi SA）

    • Table Company Profile and Development Status of Veloxis Pharmaceuticals A/S

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Veloxis Pharmaceuticals A/S

    • Figure Sales and Growth Rate Analysis of Veloxis Pharmaceuticals A/S

    • Figure Revenue and Market Share Analysis of Veloxis Pharmaceuticals A/S

    • Table Product and Service Introduction of Veloxis Pharmaceuticals A/S

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US